Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Aleksander Mendyk

Aleksander Mendyk

ThothProTM, Gdansk, Poland

Title: Open source software for comparison of dissolution profiles

Biography

Biography: Aleksander Mendyk

Abstract

Statement of the Problem: Dissolution testing has become standard tool for pharmaceutical industry both in quality control and product development. For generic companies it is a regulatory requirement to demonstrate similarity of dissolution profiles between reference product (R) and the generic product candidate (T). Several methods of dissolution profiles comparison could be classified into two main groups: (1) model based and (2) model independent. Application of any comparison method requires software to be developed for this purpose. This could be either in-house, commercial or open source. We propose open source software for calculation of FDA similarity factor (f2) and model based comparison of dissolution profiles.
Methodology: R statistical environment was chosen to write scripts and GUI (Shiny package). Bootstrap based bias corrected and accelerated confidence interval (BCa) was implemented for f2. In case of model based comparison, a method of Mahalanobis distance was chosen with Hotelling T2 test to determine similarity region for two dissolution curves. A multivariate statistical distance (MSD) for the raw dissolution profiles was also considered for the curves comparison.
Findings: Software was published on the sourceforge.net server [2, 4] under GNU GPL v3 license meaning that it is free of charge both for private and professional use. Due to the portability of R environment this software is OS–independent and was successfully tested under various Windows and Linux environments.
Conclusion & Significance: Implementation of BCa allows to use f2 for dissolution profiles comparison even when RSD exceeds 10% (20% at the first time point) and MSD is an alternative of direct curves comparison as per relevant EMA/FDA guidelines. Model based methods are commonly used for second opinion when inconclusive or borderline results of f2 analysis were found. Thus both packages enhance tooling for dissolution profiles comparison in difficult cases